Journal of Emerging Global Health

Info

Useful Links

ASSOCIATION BETWEEN COVID -19 VACCINATION AND SEVERITY AMONG THE COVID 19 PATIENTS IN URBAN BANGLADESH

Original Article | Published: 20 June 2023 | Volume: 10 Issue: 1

DOI: https://doi.org/10.36481/diujahs.v10i1.p1e51353

Nadira Mehriban

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University

Md. Shahjahan

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University

Salamat Khandker

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University

M.Omar Khaium

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University; Department of Kinesiology, University of Illinois Urbana-Champaign, USA

S.M Rezoun Shafiullah

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University

Md. Biplob Hossain

Department of Public Health, Faculty of Health and Life Sciences, Daffodil International University; Department of Public Health, Birmingham City University, Birmingham, UK

Abstract

The novel coronavirus that causes COVID-19 can be transmitted through human-to-human contact or indirectlywith contaminated objects. On March 7, 2020, Bangladesh reported the first COVID-19 case. This study aimed todetermine the prevalence of vaccination and its association with COVID -19 severity among the COVID 19 patientsin urban Bangladesh. The study used the cross-sectional survey by collecting data randomly selected COVID-19four dedicated hospitals (Both Government and Non-Government) of Dhaka city using a multistage stratifiedsampling method. In regression analysis we found significant association between vaccination and COVID-19severity level p value < 0.01 and recovery time (p=0.019) but no significant association between vaccination andage (p=0.296). In the result of ROC curve, we found severity, recovery time and occupation significantly associatedwith COVID-19 vaccination. The study revealed that approximately 25% of the patients in the trial had a moderateCOVID-19 infection. Also, the majority of patients who received vaccinations recovered in less than 14 days.

Keywords

COVID-19, Sociodemographic, Vaccination, Severity, Recovery Time

Reference

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., et al. (2020). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine, 384, 403–416.

Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. JAMA, 323(14), 1406–1407. https://doi.org/10.1001/jama.2020.2565

Bhuyan, M. A. R., Mahtab, M. A., Ashab, E., Haque, M. J., Hoque, S. M., Huq, A. F., et al. (2020). Treatment of COVID-19 patients at a medical college hospital in Bangladesh. European Journal of Hepato-Gastroenterology, 10(1), 27–30.

Bignardi, P. R., Vengrus, C. S., Aguino, B. M., & Neto, A. C. (2021). Use of hydroxychloroquine and chloroquine in patients with COVID-19: A meta-analysis of randomized clinical trials. Pathogens and Global Health, 115(3), 139–150.

COVID-19 (Coronavirus): Long term effect. (2021). Mayo Clinic.

COVID-19 live update, DGHS. (2021). Directorate General of Health Services, Bangladesh. https://dghs.gov.bd/index.php/en/home/5343-covid-19-update

COVID-19 public health emergency of international concern (PHEIC) global research and innovation forum. (2020). World Health Organization.

Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., et al. (2020). Feasibility of controlling COVID-19 outbreak by isolation of cases and contacts. The Lancet Global Health. https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(20)30074-7.pdf

Perera, W. (2020). Bangladesh government downplays COVID-19 threat as job losses mount. World Socialist Web Site.

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., et al. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 383, 2603–2615.

Tenforde, M. W., Kim, S. S., Lindsell, C. J., Rose, E. B., Shapiro, N. I., Files, C., et al. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care system network — United States, March–June 2020. Morbidity and Mortality Weekly Report (MMWR). https://www.cdc.gov/mmwr/index.html

World Health Organization. (2020, May 27). Clinical management of COVID-19: Interim report. https://apps.who.int/iris/handle/10665/332196

World Health Organization. (2021, May 8). COVID-19 clinical management: Living guidance. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1

World Health Organization. (2021, May 8). Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts

World Health Organization. (2021, May 8). What are the benefits of COVID-19 vaccines? https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines

World Health Organization. (2021, May 8). What impact does the new variant of COVID-19 virus have on vaccine? https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines

PDF Download